CVKD
Price
$12.92
Change
-$0.08 (-0.62%)
Updated
Jul 11 closing price
Capitalization
25.41M
26 days until earnings call
VYGR
Price
$3.49
Change
-$0.06 (-1.69%)
Updated
Jul 11 closing price
Capitalization
193.12M
19 days until earnings call
Interact to see
Advertisement

CVKD vs VYGR

Header iconCVKD vs VYGR Comparison
Open Charts CVKD vs VYGRBanner chart's image
Cadrenal Therapeutics
Price$12.92
Change-$0.08 (-0.62%)
Volume$26.64K
Capitalization25.41M
Voyager Therapeutics
Price$3.49
Change-$0.06 (-1.69%)
Volume$830.04K
Capitalization193.12M
CVKD vs VYGR Comparison Chart in %
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVKD vs. VYGR commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Hold and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (CVKD: $12.92 vs. VYGR: $3.49)
Brand notoriety: CVKD and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 91% vs. VYGR: 119%
Market capitalization -- CVKD: $25.41M vs. VYGR: $193.12M
CVKD [@Biotechnology] is valued at $25.41M. VYGR’s [@Biotechnology] market capitalization is $193.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • CVKD’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than CVKD.

Price Growth

CVKD (@Biotechnology) experienced а -0.46% price change this week, while VYGR (@Biotechnology) price change was +9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.14%. For the same industry, the average monthly price growth was +16.46%, and the average quarterly price growth was +20.75%.

Reported Earning Dates

CVKD is expected to report earnings on Aug 07, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($193M) has a higher market cap than CVKD($25.4M). CVKD YTD gains are higher at: -10.835 vs. VYGR (-38.448). CVKD has higher annual earnings (EBITDA): -12.82M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. CVKD (7.34M). CVKD has less debt than VYGR: CVKD (0) vs VYGR (42M). VYGR has higher revenues than CVKD: VYGR (67M) vs CVKD (0).
CVKDVYGRCVKD / VYGR
Capitalization25.4M193M13%
EBITDA-12.82M-97.25M13%
Gain YTD-10.835-38.44828%
P/E RatioN/A6.00-
Revenue067M-
Total Cash7.34M236M3%
Total Debt042M-
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVKDVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 23 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARSLF0.350.06
+19.55%
ALTIMA ENERGY INC.
DGTCF0.50N/A
N/A
DIGITIAL CORE REIT MGMT PTE LTD.
BCHHF495.77N/A
N/A
Bucher Holding AG
ELTP0.52N/A
-0.43%
Elite Pharmaceuticals, Inc.
EPOAY22.61-0.38
-1.65%
Epiroc Aktiebolag

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-0.62%
MNPR - CVKD
29%
Poorly correlated
-3.63%
GDTC - CVKD
29%
Poorly correlated
+0.45%
WHWK - CVKD
26%
Poorly correlated
-4.98%
VYGR - CVKD
24%
Poorly correlated
-1.69%
WVE - CVKD
23%
Poorly correlated
-3.14%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-1.69%
RGNX - VYGR
52%
Loosely correlated
-4.19%
XNCR - VYGR
49%
Loosely correlated
-4.85%
KYMR - VYGR
49%
Loosely correlated
-1.61%
IMNM - VYGR
47%
Loosely correlated
-3.46%
XENE - VYGR
47%
Loosely correlated
-2.33%
More